Currently holds a position at Ultralife Corp
Position | Company | Period |
---|---|---|
Independent Chairman of the Board | Ultralife Corp | March 25, 2010 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-02-12 | 2024-02-08 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
6,337
+12.3%
0.402,535 USD |
6,337 +12.3% | 0.40 | 2,535 USD | |
2024-02-12 | 2024-02-08 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
74,105
+12.3%
0.4029,642 USD |
74,105 +12.3% | 0.40 | 29,642 USD | |
2024-02-12 | 2024-02-08 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
952,697
+12.3%
0.40381,079 USD |
952,697 +12.3% | 0.40 | 381,079 USD | |
2024-02-12 | 2024-02-08 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
2,791,725
+12.3%
0.401,116,690 USD |
2,791,725 +12.3% | 0.40 | 1,116,690 USD | |
2024-02-09 | 2024-02-07 |
Clearside Biomedical Inc
(CLSD)
|
B Purchase |
444,444
+11.0%
1.35599,999 USD |
444,444 +11.0% | 1.35 | 599,999 USD | |
2023-12-08 | 2023-12-08 |
Ultralife Corp
(ULBI)
|
B Purchase |
7,000
+0.6%
7.1950,339 USD |
7,000 +0.6% | 7.19 | 50,339 USD | |
2023-12-08 | 2023-12-06 |
Ultralife Corp
(ULBI)
|
B Purchase |
8,877
+0.7%
6.8360,604 USD |
8,877 +0.7% | 6.83 | 60,604 USD | |
2023-11-29 | 2023-11-29 |
Ultralife Corp
(ULBI)
|
B Purchase |
10,740
+0.9%
7.3478,841 USD |
10,740 +0.9% | 7.34 | 78,841 USD | |
2023-11-29 | 2023-11-28 |
Ultralife Corp
(ULBI)
|
B Purchase |
11,160
+0.9%
7.0879,027 USD |
11,160 +0.9% | 7.08 | 79,027 USD | |
2023-11-29 | 2023-11-27 |
Ultralife Corp
(ULBI)
|
B Purchase |
3,200
+0.3%
7.1222,783 USD |
3,200 +0.3% | 7.12 | 22,783 USD | |
2023-09-15 | 2023-09-15 |
Ultralife Corp
(ULBI)
|
B Purchase |
3,741
+0.3%
10.2538,349 USD |
3,741 +0.3% | 10.25 | 38,349 USD | |
2023-09-15 | 2023-09-14 |
Ultralife Corp
(ULBI)
|
B Purchase |
1,600
+0.1%
10.3516,556 USD |
1,600 +0.1% | 10.35 | 16,556 USD | |
2023-09-15 | 2023-09-13 |
Ultralife Corp
(ULBI)
|
B Purchase |
5,659
+0.5%
10.0256,708 USD |
5,659 +0.5% | 10.02 | 56,708 USD | |
2023-08-23 | 2023-08-23 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
2,100
+0.0%
1.122,344 USD |
2,100 +0.0% | 1.12 | 2,344 USD | |
2023-08-23 | 2023-08-22 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
39,549
+0.1%
0.9135,954 USD |
39,549 +0.1% | 0.91 | 35,954 USD | |
2023-08-23 | 2023-08-21 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
44,198
+0.1%
0.9240,600 USD |
44,198 +0.1% | 0.92 | 40,600 USD | |
2023-06-14 | 2023-06-14 |
Ultralife Corp
(ULBI)
|
B Purchase |
33,797
+3.0%
4.97167,876 USD |
33,797 +3.0% | 4.97 | 167,876 USD | |
2023-06-05 | 2023-06-02 |
Ultralife Corp
(ULBI)
|
B Purchase |
5,964
+0.6%
4.4026,242 USD |
5,964 +0.6% | 4.40 | 26,242 USD | |
2023-06-01 | 2023-06-01 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
500
+0.0%
1.21603 USD |
500 +0.0% | 1.21 | 603 USD | |
2023-06-01 | 2023-06-01 |
Ultralife Corp
(ULBI)
|
B Purchase |
20,247
+1.9%
4.3387,607 USD |
20,247 +1.9% | 4.33 | 87,607 USD | |
2023-06-01 | 2023-05-31 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
7,700
+0.0%
1.189,079 USD |
7,700 +0.0% | 1.18 | 9,079 USD | |
2023-06-01 | 2023-05-31 |
Ultralife Corp
(ULBI)
|
B Purchase |
7,216
+0.7%
4.2830,884 USD |
7,216 +0.7% | 4.28 | 30,884 USD | |
2023-06-01 | 2023-05-30 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
8,200
+0.0%
1.189,646 USD |
8,200 +0.0% | 1.18 | 9,646 USD | |
2023-06-01 | 2023-05-30 |
Ultralife Corp
(ULBI)
|
B Purchase |
6,500
+0.6%
4.2927,901 USD |
6,500 +0.6% | 4.29 | 27,901 USD | |
2023-05-19 | 2023-05-19 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
5,650
+0.0%
1.196,737 USD |
5,650 +0.0% | 1.19 | 6,737 USD | |
2023-05-19 | 2023-05-18 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
8,200
+0.0%
1.048,541 USD |
8,200 +0.0% | 1.04 | 8,541 USD | |
2023-05-19 | 2023-05-17 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
53,040
+0.2%
0.7740,920 USD |
53,040 +0.2% | 0.77 | 40,920 USD | |
2023-03-13 | 2023-03-13 |
Ultralife Corp
(ULBI)
|
B Purchase |
14,338
+1.4%
4.0758,356 USD |
14,338 +1.4% | 4.07 | 58,356 USD | |
2023-03-13 | 2023-03-10 |
Ultralife Corp
(ULBI)
|
B Purchase |
10,100
+1.0%
4.0540,895 USD |
10,100 +1.0% | 4.05 | 40,895 USD | |
2023-03-13 | 2023-03-09 |
Ultralife Corp
(ULBI)
|
B Purchase |
5,562
+0.6%
4.0722,642 USD |
5,562 +0.6% | 4.07 | 22,642 USD | |
2022-12-16 | 2022-12-16 |
Ultralife Corp
(ULBI)
|
B Purchase |
7,200
+0.7%
3.9828,683 USD |
7,200 +0.7% | 3.98 | 28,683 USD | |
2022-12-16 | 2022-12-15 |
Ultralife Corp
(ULBI)
|
B Purchase |
5,138
+0.5%
3.9420,249 USD |
5,138 +0.5% | 3.94 | 20,249 USD | |
2022-12-15 | 2022-12-15 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
300,488
+1.0%
1.10330,597 USD |
300,488 +1.0% | 1.10 | 330,597 USD | |
2022-12-16 | 2022-12-14 |
Ultralife Corp
(ULBI)
|
B Purchase |
25,694
+2.7%
4.01103,030 USD |
25,694 +2.7% | 4.01 | 103,030 USD | |
2022-12-08 | 2022-12-08 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
92,000
+0.3%
1.16107,033 USD |
92,000 +0.3% | 1.16 | 107,033 USD | |
2022-12-08 | 2022-12-08 |
Ultralife Corp
(ULBI)
|
B Purchase |
28,600
+3.1%
4.12117,821 USD |
28,600 +3.1% | 4.12 | 117,821 USD | |
2022-12-08 | 2022-12-07 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
450
+0.0%
1.17527 USD |
450 +0.0% | 1.17 | 527 USD | |
2022-12-08 | 2022-12-07 |
Ultralife Corp
(ULBI)
|
B Purchase |
19,600
+2.2%
3.9777,775 USD |
19,600 +2.2% | 3.97 | 77,775 USD | |
2022-12-08 | 2022-12-06 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
86,318
+0.3%
1.22105,308 USD |
86,318 +0.3% | 1.22 | 105,308 USD | |
2022-12-08 | 2022-12-06 |
Ultralife Corp
(ULBI)
|
B Purchase |
20,996
+2.4%
3.9683,134 USD |
20,996 +2.4% | 3.96 | 83,134 USD | |
2022-11-18 | 2022-11-18 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
73,400
+0.2%
1.40102,760 USD |
73,400 +0.2% | 1.40 | 102,760 USD | |
2022-11-18 | 2022-11-17 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
47,160
+0.2%
1.3865,076 USD |
47,160 +0.2% | 1.38 | 65,076 USD | |
2022-11-18 | 2022-11-16 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
12,625
+0.0%
1.4017,662 USD |
12,625 +0.0% | 1.40 | 17,662 USD | |
2022-08-19 | 2022-08-18 |
Ultralife Corp
(ULBI)
|
B Purchase |
17,700
+2.1%
4.6482,211 USD |
17,700 +2.1% | 4.64 | 82,211 USD | |
2022-08-19 | 2022-08-17 |
Ultralife Corp
(ULBI)
|
B Purchase |
16,400
+2.0%
4.6075,417 USD |
16,400 +2.0% | 4.60 | 75,417 USD | |
2022-08-04 | 2022-08-04 |
Ultralife Corp
(ULBI)
|
B Purchase |
40,052
+5.0%
4.73189,258 USD |
40,052 +5.0% | 4.73 | 189,258 USD | |
2022-08-04 | 2022-08-03 |
Ultralife Corp
(ULBI)
|
B Purchase |
29,100
+3.8%
4.68136,331 USD |
29,100 +3.8% | 4.68 | 136,331 USD | |
2022-08-04 | 2022-08-02 |
Ultralife Corp
(ULBI)
|
B Purchase |
30,848
+4.2%
4.60141,898 USD |
30,848 +4.2% | 4.60 | 141,898 USD | |
2022-06-08 | 2022-06-08 |
Ultralife Corp
(ULBI)
|
B Purchase |
30,690
+4.3%
5.20159,554 USD |
30,690 +4.3% | 5.20 | 159,554 USD | |
2022-06-08 | 2022-06-06 |
Ultralife Corp
(ULBI)
|
B Purchase |
12,280
+1.8%
4.8659,698 USD |
12,280 +1.8% | 4.86 | 59,698 USD | |
2022-02-28 | 2022-02-28 |
Ultralife Corp
(ULBI)
|
B Purchase |
30
+0.0%
5.22157 USD |
30 +0.0% | 5.22 | 157 USD | |
2022-02-28 | 2022-02-25 |
Ultralife Corp
(ULBI)
|
B Purchase |
100
+0.0%
5.14514 USD |
100 +0.0% | 5.14 | 514 USD | |
2022-02-28 | 2022-02-24 |
Ultralife Corp
(ULBI)
|
B Purchase |
54,900
+8.5%
4.44244,020 USD |
54,900 +8.5% | 4.44 | 244,020 USD | |
2021-12-23 | 2021-12-21 |
Nanophase Technologies Corp
(NANX)
|
B Purchase |
7,731,573
+inf%
4.1932,361,272 USD |
7,731,573 +inf% | 4.19 | 32,361,272 USD | |
2021-12-23 | 2021-12-21 |
Nanophase Technologies Corp
(NANX)
|
S Sale |
7,731,573
-26.1%
4.1932,361,272 USD |
7,731,573 -26.1% | 4.19 | 32,361,272 USD | |
2021-12-20 | 2021-12-17 |
Ultralife Corp
(ULBI)
|
B Purchase |
53,251
+9.0%
5.57296,624 USD |
53,251 +9.0% | 5.57 | 296,624 USD | |
2021-01-07 | 2021-01-06 |
Clearside Biomedical Inc
(CLSD)
|
B Purchase |
350,750
+11.0%
2.85999,988 USD |
350,750 +11.0% | 2.85 | 999,988 USD | |
2020-12-28 | 2020-12-24 |
Clearside Biomedical Inc
(CLSD)
|
B Purchase |
51,195
+1.6%
1.9599,897 USD |
51,195 +1.6% | 1.95 | 99,897 USD | |
2020-12-02 | 2020-12-02 |
Clearside Biomedical Inc
(CLSD)
|
B Purchase |
53,900
+1.8%
1.95105,051 USD |
53,900 +1.8% | 1.95 | 105,051 USD | |
2020-11-24 | 2020-11-24 |
Clearside Biomedical Inc
(CLSD)
|
B Purchase |
62,000
+2.1%
1.65102,046 USD |
62,000 +2.1% | 1.65 | 102,046 USD | |
2020-11-16 | 2020-11-16 |
Clearside Biomedical Inc
(CLSD)
|
B Purchase |
62,000
+2.1%
1.69104,929 USD |
62,000 +2.1% | 1.69 | 104,929 USD | |
2020-08-13 | 2020-08-13 |
Clearside Biomedical Inc
(CLSD)
|
B Purchase |
50,000
+1.7%
1.6582,560 USD |
50,000 +1.7% | 1.65 | 82,560 USD | |
2020-08-13 | 2020-08-12 |
Clearside Biomedical Inc
(CLSD)
|
B Purchase |
300,000
+11.5%
1.63489,120 USD |
300,000 +11.5% | 1.63 | 489,120 USD | |
2020-05-18 | 2020-05-14 |
Ultralife Corp
(ULBI)
|
B Purchase |
5,000
+0.9%
7.4337,147 USD |
5,000 +0.9% | 7.43 | 37,147 USD | |
2020-05-11 | 2020-05-11 |
Ultralife Corp
(ULBI)
|
B Purchase |
1,379
+0.2%
8.3011,446 USD |
1,379 +0.2% | 8.30 | 11,446 USD | |
2020-05-11 | 2020-05-08 |
Ultralife Corp
(ULBI)
|
B Purchase |
3,800
+0.7%
8.1831,076 USD |
3,800 +0.7% | 8.18 | 31,076 USD | |
2020-05-11 | 2020-05-07 |
Ultralife Corp
(ULBI)
|
B Purchase |
3,631
+0.7%
8.0529,242 USD |
3,631 +0.7% | 8.05 | 29,242 USD | |
2020-05-06 | 2020-05-06 |
Ultralife Corp
(ULBI)
|
B Purchase |
2,678
+0.5%
8.3622,394 USD |
2,678 +0.5% | 8.36 | 22,394 USD | |
2020-05-06 | 2020-05-05 |
Ultralife Corp
(ULBI)
|
B Purchase |
2,978
+0.5%
8.3824,965 USD |
2,978 +0.5% | 8.38 | 24,965 USD | |
2020-05-06 | 2020-05-04 |
Ultralife Corp
(ULBI)
|
B Purchase |
5,534
+1.0%
7.6442,290 USD |
5,534 +1.0% | 7.64 | 42,290 USD | |
2020-03-17 | 2020-03-17 |
Ultralife Corp
(ULBI)
|
B Purchase |
2,233
+0.4%
6.1913,821 USD |
2,233 +0.4% | 6.19 | 13,821 USD | |
2020-03-17 | 2020-03-17 |
Ultralife Corp
(ULBI)
|
B Purchase |
30,092
+5.9%
5.37161,513 USD |
30,092 +5.9% | 5.37 | 161,513 USD | |
2020-03-17 | 2020-03-16 |
Ultralife Corp
(ULBI)
|
B Purchase |
1,703
+0.3%
5.238,914 USD |
1,703 +0.3% | 5.23 | 8,914 USD | |
2020-03-17 | 2020-03-13 |
Ultralife Corp
(ULBI)
|
B Purchase |
15,972
+3.3%
5.6990,812 USD |
15,972 +3.3% | 5.69 | 90,812 USD | |
2020-02-20 | 2020-02-19 |
Ultralife Corp
(ULBI)
|
B Purchase |
58,845
+13.7%
7.16421,277 USD |
58,845 +13.7% | 7.16 | 421,277 USD |